Literature DB >> 17187284

Non-standard PET radionuclides: time to get ready for new clinical PET strategies.

Giovanni Lucignani1.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17187284     DOI: 10.1007/s00259-006-0330-0

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  16 in total

1.  Validation of a novel CHX-A'' derivative suitable for peptide conjugation: small animal PET/CT imaging using yttrium-86-CHX-A''-octreotide.

Authors:  Thomas Clifford; C Andrew Boswell; Grainne B Biddlecombe; Jason S Lewis; Martin W Brechbiel
Journal:  J Med Chem       Date:  2006-07-13       Impact factor: 7.446

2.  Optimization of 124I production via 124Te(p,n)124I reaction.

Authors:  Munawwar Sajjad; Erol Bars; H A Nabi
Journal:  Appl Radiat Isot       Date:  2006-05-24       Impact factor: 1.513

3.  Combined I-124 positron emission tomography/computed tomography imaging of NIS gene expression in animal models of stably transfected and intravenously transfected tumor.

Authors:  David Dingli; Brad J Kemp; Michael K O'Connor; John C Morris; Stephen J Russell; Val J Lowe
Journal:  Mol Imaging Biol       Date:  2006 Jan-Feb       Impact factor: 3.488

Review 4.  Alternative positron emission tomography with non-conventional positron emitters: effects of their physical properties on image quality and potential clinical applications.

Authors:  M Pagani; S Stone-Elander; S A Larsson
Journal:  Eur J Nucl Med       Date:  1997-10

5.  Bispecific antibody pretargeting PET (immunoPET) with an 124I-labeled hapten-peptide.

Authors:  William J McBride; Pat Zanzonico; Robert M Sharkey; Carl Norén; Habibe Karacay; Edmund A Rossi; Michele J Losman; Pierre-Yves Brard; Chien-Hsing Chang; Steven M Larson; David M Goldenberg
Journal:  J Nucl Med       Date:  2006-10       Impact factor: 10.057

6.  Feasibility of central cannabinoid CB1 receptor imaging with [124I]AM281 PET demonstrated in a schizophrenic patient.

Authors:  Georg Berding; Udo Schneider; Peter Gielow; Ralph Buchert; Frank Donnerstag; Wolfgang Brandau; Wolfram H Knapp; Hinderk M Emrich; Kirsten Müller-Vahl
Journal:  Psychiatry Res       Date:  2006-03-06       Impact factor: 3.222

7.  A simple and selective method for the separation of Cu radioisotopes from nickel.

Authors:  Xianfeng Fan; David J Parker; Mike D Smith; Andy Ingram; Zhufang Yang; Jonathan P K Seville
Journal:  Nucl Med Biol       Date:  2006-10       Impact factor: 2.408

8.  MicroPET imaging of breast cancer using radiolabeled bombesin analogs targeting the gastrin-releasing peptide receptor.

Authors:  Jesse J Parry; Rebecca Andrews; Buck E Rogers
Journal:  Breast Cancer Res Treat       Date:  2006-07-13       Impact factor: 4.872

9.  Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone).

Authors:  Hong Yuan; Thies Schroeder; James E Bowsher; Laurence W Hedlund; Terence Wong; Mark W Dewhirst
Journal:  J Nucl Med       Date:  2006-06       Impact factor: 10.057

10.  In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM.

Authors:  Farrokh Dehdashti; Mark A Mintun; Jason S Lewis; Jeffrey Bradley; Ramaswamy Govindan; Richard Laforest; Michael J Welch; Barry A Siegel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-12       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.